What Is SLU-PP-332 Used For in Research?
SLU-PP-332 is a synthetic small-molecule agonist targeting estrogen-related receptors (ERRs), primarily investigated in preclinical models of cellular energy metabolism. Researchers utilize this compound to evaluate mitochondrial biogenesis, gene expression, and oxidative capacity in vitro and in rodent assay systems. PX1 Research supplies high-purity research compounds strictly for laboratory research and in vitro evaluation.
Quick answer
SLU-PP-332 is a synthetic small-molecule agonist targeting estrogen-related receptors (ERRs), primarily investigated in preclinical models of cellular energy metabolism. Researchers utilize this compound to evaluate mitochondrial biogenesis, gene expression, and oxidative capacity in vitro and in rodent assay systems. PX1 Research supplies high-purity research compounds strictly for laboratory research and in vitro evaluation.
Key takeaways
- In preclinical research, SLU-PP-332 is used as a selective pan-agonist of Estrogen-Related Receptors (ERRα, ERRβ, and ERRγ) to investigate nuclear receptor signaling, cellular respiration, mitochondrial biogenesis, and skeletal muscle energy transcription pathways in cell culture and rodent models.
- The primary biological activity of SLU-PP-332 centers on its potent activation of the three orphan nuclear receptor isoforms: ERRα, ERRβ, and ERRγ.
- In vitro models represent a major application area for SLU-PP-332 research.
- Beyond cell culture systems, SLU-PP-332 is widely evaluated in murine and rodent model systems to quantify systemic metabolic endpoints.
Overview and Primary Research Uses of SLU-PP-332
In preclinical research, SLU-PP-332 is used as a selective pan-agonist of Estrogen-Related Receptors (ERRα, ERRβ, and ERRγ) to investigate nuclear receptor signaling, cellular respiration, mitochondrial biogenesis, and skeletal muscle energy transcription pathways in cell culture and rodent models.
As an experimental synthetic compound, SLU-PP-332 serves as a pivotal chemical tool for mapping nuclear receptor dynamics. Discovered through targeted drug design at Saint Louis University, it selectively activates the ERR family of nuclear receptors without displaying significant cross-reactivity with classical estrogen receptors (ERα and ERβ). This specificity enables investigators to dissect ERR-dependent transcriptomic cascades independently of endocrine signaling pathways.
In academic and industrial laboratory settings, researchers incorporate SLU-PP-332 into experimental workflows to probe metabolic adaptation, mitochondrial density variations, and substrate oxidation rates. The compound is supplied strictly as a analytical reagent for in vitro and animal models to advance baseline knowledge in biochemical and metabolic science.
Estrogen-Related Receptor (ERR) Agonism and Molecular Mechanisms
The primary biological activity of SLU-PP-332 centers on its potent activation of the three orphan nuclear receptor isoforms: ERRα, ERRβ, and ERRγ. These receptors act as master transcriptional regulators of cellular energy metabolism, controlling networks of genes responsible for mitochondrial electron transport, fatty acid oxidation, and pyruvate oxidation.
When SLU-PP-332 binds to the ligand-binding domain of ERR isoforms, it induces a conformational shift that recruits coactivator proteins, most notably peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α). This coactivator interaction amplifies the transcription of nuclear-encoded mitochondrial genes. Preclinical data indicate that this activation bypasses the necessity for physical exercise signaling cascades to stimulate basal ERR activity.
By utilizing selective ERR agonists, biological researchers can interrogate how downstream effector genes, such as cytochrome c, citrate synthase, and medium-chain acyl-CoA dehydrogenase (MCAD), respond under controlled nutrient conditions in vitro. Understanding these mechanisms contributes valuable baseline data to metabolic research topics centered on cellular energy homeostasis.
In Vitro Model Applications: Cell Line Signaling and Respiration
In vitro models represent a major application area for SLU-PP-332 research. Investigators routinely introduce the compound into cultured cell lines—including C2C12 myotubes, 3T3-L1 adipocytes, and primary hepatocytes—to measure real-time changes in cellular bioenergetics. Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) assays are commonly employed to evaluate oxidative phosphorylation efficiency following treatment.
Cellular assays demonstrate that exposure to SLU-PP-332 leads to an upregulation of mitochondrial protein expression and increased baseline respiration without inducing uncoupling stress. Researchers measure mitochondrial membrane potential using fluorometric probes and quantify mitochondrial DNA (mtDNA) copy numbers relative to nuclear DNA (nDNA) to confirm organelle proliferation.
In vitro models also leverage SLU-PP-332 to examine glucose uptake mechanisms, insulin sensitivity markers, and lipid accumulation parameters under normoxic and hypoxic cell culture conditions. These cellular assays provide essential foundational data prior to executing complex in vivo protocols.
Rodent Model Systems and Metabolic Performance Endpoints
Beyond cell culture systems, SLU-PP-332 is widely evaluated in murine and rodent model systems to quantify systemic metabolic endpoints. Researchers administering SLU-PP-332 in high-fat diet (HFD) rodent models assess parameters such as total energy expenditure, body composition shifts, and resting metabolic rates using indirect calorimetry cages.
Preclinical animal studies report that rodent models treated with ERR agonists exhibit enhanced endurance capacity during treadmill testing, driven by a shift in skeletal muscle fiber phenotype toward oxidative Type I and Type IIa fibers. These phenotypical changes occur alongside elevated gene expression for fatty acid transport proteins (such as CD36 and CPT-1b).
Endpoints systematically evaluated in these rodent assays include fasting plasma glucose levels, serum triglyceride clearance rates, hepatic steatosis grading via histological staining, and maximal oxygen consumption (VO2 max) metrics during controlled physical exertion protocols.
Mitochondrial Biogenesis and Gene Expression Analysis
A primary endpoint for laboratory researchers evaluating SLU-PP-332 is the quantitative measurement of mitochondrial biogenesis markers. Real-time quantitative PCR (RT-qPCR) and Western blot analyses are standard analytical techniques used to assess gene expression and protein abundance in tissue samples isolated from experimental models.
Key molecular targets evaluated during SLU-PP-332 assays include nuclear respiratory factor 1 (NRF-1), mitochondrial transcription factor A (TFAM), and various subunits of the mitochondrial respiratory chain complexes (Complexes I through V). Upregulation of these markers serves as direct biochemical evidence of ERR-mediated transcriptional activation.
Additionally, researchers measure total ATP production rates, citrate synthase enzyme kinetics, and reactive oxygen species (ROS) accumulation to ensure that accelerated mitochondrial biogenesis maintains structural integrity and cellular redox equilibrium within the test models.
Comparative Analysis: SLU-PP-332 vs. Other Metabolic Modulators
In metabolic research, SLU-PP-332 is frequently compared against other small molecules and peptides designed to modulate energy pathways, such as GW501516, SR9009, and AICA-Riboside. While each of these compounds targets metabolic acceleration, their primary molecular receptors and intracellular pathways remain distinct.
Unlike GW501516, which acts as a selective agonist for the peroxisome proliferator-activated receptor delta (PPARδ), SLU-PP-332 targets the ERR family directly. While PPARδ and ERR pathways share downstream gene overlaps involved in fatty acid oxidation, ERR activation directly controls a broader network of respiratory chain components. Similarly, SR9009 operates as a Rev-ErbA agonist influencing circadian metabolic rhythms, whereas SLU-PP-332 functions independently of core clock gene regulation.
Understanding these subtle distinctions allows comparative metabolic researchers to design multi-compound control arms in experimental studies, elucidating how overlapping pathways contribute to overall cellular bioenergetics and physical endurance metrics in preclinical models.
Analytical Purity, Quality Standards, and COA Verification
Data integrity in laboratory experiments depends entirely on the chemical purity and consistency of the subject reagents. Impurities, residual solvents, or heavy metal contamination can introduce confounding variables, skewing cell viability assays and metabolic readings.
PX1 Research ensures that every lot of SLU-PP-332 undergoes rigorous analytical validation in an ISO 17025 accredited laboratory facility. Purity is verified using high-performance liquid chromatography (HPLC) and mass spectrometry (MS) to guarantee chemical identity and a minimum purity standard of 98%. Additionally, lot-specific testing includes bacterial endotoxin screening to ensure suitability for sensitive cell culture environments.
Researchers can review transparent documentation by visiting our dedicated Certificate of Analysis (COA) portal, where full analytical spectra and lot verification certificates are publicly accessible for every batch produced.
Laboratory Preparation, Storage, and Reconstitution Metrics
Proper handling and solution preparation are critical when working with synthetic ERR agonists in a laboratory setting. SLU-PP-332 is hydrophobic in nature and exhibits limited solubility in aqueous buffers without the aid of organic co-solvents such as dimethyl sulfoxide (DMSO) or ethanol.
To prepare stock solutions for in vitro application, researchers typically dissolve solid SLU-PP-332 powder in high-purity DMSO to achieve desired stock concentrations, before diluting into cell culture media. Stock solutions should be aliquoted and stored at -80°C to prevent degradation from repeated freeze-thaw cycles. Lyophilized compounds and peptides sourced across our catalog should be handled in accordance with precise laboratory calculations available on our reconstitution calculator.
When designing animal administration vehicles, researchers utilize specialized non-toxic formulations such as PEG400, Tween-80, or cyclodextrin carriers to maintain compound stability and bio-accessibility without compromising subject safety or trial parameters.
Bulk Procurement and Institutional Sourcing Standards
Academic institutions, contract research organizations (CROs), and biotechnology firms require consistent lot-to-lot reliability and reliable supply chains to conduct long-term longitudinal studies. Variations in active compound concentrations can invalidate months of experimental trial data.
PX1 Research manufactures all research compounds within USA-based, GMP-compliant facilities. Orders are processed with same-day dispatch from our CA and AZ distribution centers (Monday through Friday), ensuring rapid fulfillment for time-sensitive scientific schedules.
Principal investigators seeking high-volume supply for large-scale animal cohorts or high-throughput screen arrays can access custom packaging and bulk pricing through our wholesale portal, or explore our complete catalog of research peptides and small molecules.
Frequently Asked Questions
What is the primary molecular target of SLU-PP-332 in research?
SLU-PP-332 acts as a selective pan-agonist of the Estrogen-Related Receptors (ERRα, ERRβ, and ERRγ), which regulate nuclear transcription of mitochondrial and metabolic genes.
Is SLU-PP-332 intended for human or clinical use?
No. SLU-PP-332 is strictly supplied as a chemical reagent for in vitro and preclinical laboratory research only. It is not intended for human or animal therapeutic use, dosing, or consumption.
How do researchers verify the purity of SLU-PP-332 lots from PX1 Research?
PX1 Research provides independent, third-party Certificates of Analysis (COAs) for every lot, utilizing HPLC and MS analysis in ISO 17025 accredited laboratories to confirm chemical identity and ≥98% purity.
What solvent is recommended for dissolving SLU-PP-332 for cell culture assays?
SLU-PP-332 is hydrophobic and generally requires organic solvents such as DMSO or ethanol to prepare primary stock solutions prior to downstream dilution in aqueous media.
What endpoints are evaluated in SLU-PP-332 rodent studies?
Commonly evaluated endpoints in murine studies include oxygen consumption rate (VO2 max), treadmill running endurance, basal metabolic rate, mitochondrial gene expression, and tissue lipid accumulation.
How does SLU-PP-332 differ from PPAR delta agonists like GW501516?
While both target energy metabolism, SLU-PP-332 selectively targets the Estrogen-Related Receptor (ERR) family, whereas GW501516 selectively activates the PPARδ receptor pathway.
What are the recommended storage conditions for SLU-PP-332?
Lyophilized powder should be stored sealed at -20°C in a dry environment. Liquid stock solutions in DMSO should be aliquoted and maintained at -80°C to minimize degradation.
Where are PX1 Research compounds manufactured and shipped from?
All PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities and shipped directly from distribution centers in California and Arizona with same-day dispatch M–F.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.